Delhivery, Fortis Healthcare, and Cummins India are looking bullish on technical charts. While many companies have reported strong numbers, Indian markets are facing uncertainty due to tariffs announced by US President Donald Trump. Investors are concerned about the short term impact of tariffs on Indian exports. Delhivery, Fortis Healthcare, and Cummins India, each delivering robust financial results, strategic innovation, and notable market moves in Q1FY26. Delhivery’s profitability surge and game-changing acquisition, Fortis Healthcare’s aggressive expansion and premium valuation, and Cummins India’s unrivaled export momentum shape the current narrative. TopNews Team has reviewed levels for these three stocks for short term investors and traders.

Delhivery: Operational Excellence and Strategic Expansion

Delhivery, India’s premier logistics integrator, continues its upward trajectory, sparking investor optimism with a 68.5% year-on-year growth in net profit, reaching ₹91 crore for Q1FY26. The company’s revenue rose 5.6% year-on-year to ₹2,294 crore, a gain powered by operational efficiencies and a 14% increase in express parcel shipments, hitting 208 million parcels. Such scalable volume growth underscores the strength and versatility of Delhivery’s business fundamentals.

A defining chapter is Delhivery’s acquisition of Ecom Express, expected to catapult its 3PL market share by nearly 25%. CEO Sahil Barua revealed that integration is underway, supported by a planned ₹300 crore investment over six months. Regulatory endorsement by the Competition Commission of India fortifies Delhivery’s majority control, paving the way for network consolidation and supply chain expansion. Analysts widely anticipate transformational synergies, forecasting advantages in market share and operational costs.

Stock Momentum and Technical Indicators

Following these results and the Ecom Express deal, Delhivery’s stock surged up to 6%, marked by a new 52-week high and year-to-date gains of 23%. Over the past three months, the stock advanced 41%, showcasing resilience despite trailing twelve-month declines. Technical analysis highlights strength above multiple key moving averages and a relative strength index of 60.2, placing the stock in a zone of neutral momentum and average volatility.

Analyst Sentiment and Targets

Broker opinions remain bullish. Motilal Oswal Financial Services raised Delhivery’s target price to ₹500, praising scalable growth, network synergies, and asset optimization. Sustainable transport margins of 16–18% are projected, while forecasts include a 14% CAGR in sales, 38% in EBITDA, and 53% in adjusted PAT through FY25–28. Geojit offers an ‘Accumulate’ stance at ₹431, favoring cost structure improvement and sector outlook. Nuvama Institutional Equities is even more bullish, upgrading to ₹525, citing Express Parcel and partial truckload advantages. Jefferies, diverging from consensus, downgraded Delhivery, concerned by competitive threats from rivals like Meesho and growth deceleration in the express parcel segment.

Strategic Initiatives and Board Evolution

Delhivery is doubling down on innovation with Transport One, an AI-driven freight management platform targeting India’s manufacturing sector, accelerating its transition to SaaS and digital logistics for scalable revenue. A refresh in board leadership sees Srivatsan Rajan stepping down, succeeded by Yashish Dahiya and Padmini Srinivasan—moves expected to enrich oversight and strategic vision.

Risks and Near-Term Signals

Technical indicators, such as stochastic crossover, suggest short-term gains are likely—historically a 6.95% upside within seven weeks post-signal. However, Delhivery faces risks from sector rivalry and operational challenges post-Ecom Express integration, demanding vigilant investor attention.

Fortis Healthcare: Riding a Wave of Expansion and Value

Fortis Healthcare has rapidly ascended the ranks of India’s hospital sector, propelled by stellar financial performance. The company delivered a 7.65% sequential and 13.25% annual revenue growth in Q1FY26, marking its strongest showings in three years. These gains surpass Fortis’s three-year CAGR of 10.85%, driven by lowering interest expenses and stable payroll outlays.

The stock price reflects these strengths, reaching a 52-week high of ₹904.50, surging 35.4% over three months and 83.45% year-on-year. With a market capitalization of ₹67,746 crore, Fortis now stands as the third-largest player in hospitals and allied services. However, the valuation is notably rich: a present PE ratio of 76.84 and PB of 7.28 mean Fortis trades at a 232% premium to estimated intrinsic value, possibly foreshadowing resistance.

Analyst Outlook and Ratings

Consensus remains bullish, led by Axis Securities, which has issued several ‘BUY’ ratings with targets up to ₹860. Of 13 analysts, nine advocate ‘Buy’ and four recommend ‘Strong Buy’, with none advising a reduction or sale. This signals strong confidence in Fortis’s business drivers and operational tailwinds.

Growth Strategies and Sector Drivers

Expansion is central to Fortis’s playbook: the intent to add 900 beds and target 14–15% revenue growth in FY26 underpins analysts’ bullishness. The strategy favors growth into secondary cities, building a broader geographic footprint. Improving EBITDA margins, swelling patient volumes, and digital diagnostics are buoying sentiment among both investors and market watchers.

Risks and Technical Considerations

Despite strong momentum, valuation warnings persist, with PE ratios at historic highs. Technical charts show resistance at ₹904.50 and support at ₹882 and ₹868, suggesting plateau risks in absence of new growth drivers. Investors are advised to closely monitor expansion milestones and valuation metrics to maintain a prudent stance.

Macro Backdrop

Fortis is strategically positioned in a sector benefitting from expanding middle-class income, increased insurance uptake, and the growth of medical tourism. Nonetheless, looming regulatory changes and intensifying competition remain potential headwinds.

Cummins India: Sustained Earnings and Export Expansion

Cummins India’s recent performance cements its status as an industrial mainstay. Q1FY26 saw standalone net profit jump 40% year-on-year to ₹589 crore, and quarterly profit up 30.5% YOY to ₹604 crore. Revenue climbed 25.7% to ₹2,859 crore, testament to robust domestic and export demand.

Export sales, growing 34% to ₹523 crore YOY, highlight Cummins’ ability to gain ground abroad despite turbulent global trade conditions. The stock responded accordingly, climbing 3–5% post-results to ₹3,806.90 as of August 8, 2025. Technical analysts note a breakout from an ascending triangle pattern, a bullish sign, with the stock up 37.4% in three months, 6.67% in a week, but just 2.1% year-to-date.

Brokerage Views and Management Guidance

ICICI Securities maintains a ‘Buy’ rating with a revised target of ₹3,100, appraising Cummins on FY27E earnings and export leadership. Motilal Oswal is even more positive, setting a target at ₹4,300 and citing growth conviction backed by technical indicators. Of the 22 analysts following Cummins, 13 recommend ‘Buy’ or ‘Strong Buy’, reinforcing a consensus view of upside potential.

Managing Director Shveta Arya projects continued opportunity, anchored by India’s government-led infrastructure push and lower interest rates fostering growth in a benign inflation climate. Arya underscores the priority of operational efficiencies and cost management, considering the current trajectory durable amid solid demand and improved order execution—even as global trade turmoil persists.

Shareholder Activity and Technicals

With FIIs holding 17% ownership, Cummins India remains a preferred pick among institutional players. The stock’s PE ratio, at 50.92 and PB of 13.47, denote a premium valuation, but its market capitalization of ₹1,05,527 crore secures its position as a sector leader.

Risks and Strategic Outlook

Major risks stem from possible global trade disruptions and foreign inflationary shocks. Even so, strong domestic fundamentals, aided by infrastructure investment, underpin a sustainable outlook. Cummins is actively pursuing further operational gains to protect margins and optimize returns for shareholders.

Short Term View

Delhivery’s robust operational results, bold M&A, and favorable analyst consensus signal ongoing opportunities for upside—especially as Ecom Express integration matures. Investors should track the next quarter’s earnings and watch for competitive threats to sector leadership.

Fortis Healthcare’s aggressive expansion, bed additions, and technical milestones position it for continued growth, but stretched valuations and resistance levels call for measured optimism. Monitoring progress on geographic expansion and revenue sustainability will be crucial.

Cummins India exemplifies steady earnings ascent, strong export momentum, and prudent management, but global volatility and high valuation merit close scrutiny. The company’s ability to adapt and innovate will be central to sustaining share price momentum.